CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 3, Multi-Center, Randomized, Open-Label Study of Vabomere(Meropenem-vaborbactam) Versus Best Available Therapy in Subjects With Selected Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (CRE)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02168946
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:23.219475+00:00
Published At: 2018-12-11T00:00:00+00:00
Record Updated At: 2019-03-04
Results Posted At: 2018-12-11
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Urinary Tract Infection Complicated", "Acute Pyelonephritis", "Hospital Acquired Bacterial Pneumonia", "Ventilator-associated Bacterial Pneumonia", "Bacteremia", "Abdominal Infection"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2019-03-04"
protocolSection.identificationModule.nctId: "NCT02168946"
protocolSection.identificationModule.officialTitle: "A Phase 3, Multi-Center, Randomized, Open-Label Study of Vabomere(Meropenem-vaborbactam) Versus Best Available Therapy in Subjects With Selected Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae (CRE)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-12-11"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.